David Angulo Gonzalez
Vorstandsvorsitzender bei SCYNEXIS, INC.
Vermögen: 705 410 $ am 30.04.2024
Profil
David Angulo Gonzalez is currently the President, Chief Executive Officer & Director at SCYNEXIS, Inc. He previously worked as the Project Director-Clinical Research at Schering-Plough Corp.
from 1998 to 2006.
From 2010 to 2015, he was the Vice President-Research & Development at Brickell Subsidiary, Inc. Prior to that, he served as the Vice President-Clinical Research at Stiefel Laboratories, Inc. from 2006 to 2010.
Dr. Angulo Gonzalez holds a doctorate degree from the University of Guadalajara.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCYNEXIS, INC.
1,27% | 31.03.2024 | 479 871 ( 1,27% ) | 705 410 $ | 30.04.2024 |
Aktive Positionen von David Angulo Gonzalez
| Unternehmen | Position | Beginn |
|---|---|---|
| SCYNEXIS, INC. | Vorstandsvorsitzender | 01.01.2023 |
Ehemalige bekannte Positionen von David Angulo Gonzalez
| Unternehmen | Position | Ende |
|---|---|---|
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2015 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2010 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von David Angulo Gonzalez
| University of Guadalajara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCYNEXIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
